We are running this funding opportunity on the new UK Research and Innovation (UKRI) Funding Service so please ensure that your organisation is registered. You cannot apply on the Joint Electronic Submissions (Je-S) system.
The project lead is responsible for completing the application process on the Funding Service, but we expect all team members and project partners to contribute to the application.
If the lead research organisation is an NHS organisation, check it is available in the Funding Service. You are encouraged to check this early as there may be additional steps for the organisation to be set up before you can apply.
Only the lead research organisation can submit an application to UKRI.
To apply
You can only apply for this funding opportunity if we have invited you to do so following a successful stage one application. The start application link will be provided via email.
- Confirm you are the project lead.
- Sign in or create a Funding Service account. To create an account, select your organisation, verify your email address, and set a password. If your organisation is not listed, email support@funding-service.ukri.org
Please allow at least 10 working days for your organisation to be added to the Funding Service. We strongly suggest that if you are asking UKRI to add your organisation to the Funding Service to enable you to apply to this opportunity, you also create an organisation Administration Account. This will be needed to allow the acceptance and management of any grant that might be offered to you.
- Answer questions directly in the text boxes. You can save your answers and come back to complete them or work offline and return to copy and paste your answers. If we need you to upload a document, follow the upload instructions in the Funding Service. All questions and assessment criteria are listed in the How to apply section on this Funding finder page.
- Allow enough time to check your application in ‘read-only’ view before sending to your research office.
- Send the completed application to your research office for checking. They will return it to you if it needs editing.
- Your research office will submit the completed and checked application to UKRI.
Where indicated, you can also demonstrate elements of your responses in visual form if relevant:
- use images sparingly and only to convey important information that cannot easily be put into words
- insert each new image onto a new line
- provide a descriptive legend for each image immediately underneath it (this counts towards your word limit)
- files must be smaller than 5MB and in JPEG, JPG, JPE, JFI, JIF, JFIF, PNG, GIF, BMP or WEBP format
Watch our research office webinars about the new Funding Service.
For more guidance on the Funding Service, see:
References
Applications should be self-contained, and hyperlinks should only be used to provide links directly to reference information. To ensure the information’s integrity is maintained, where possible, persistent identifiers such as digital object identifiers should be used. Assessors are not required to access links to carry out assessment or recommend a funding decision. Applicants should use their discretion when including references and prioritise those most pertinent to the application.
References should be included in the appropriate question section of the application and be easily identifiable by the assessors, for example (Smith, Research Paper, 2019).
You must not include links to web resources to extend your application.
Generative artificial intelligence (AI)
Use of generative AI tools to prepare funding applications is permitted, however, caution should be applied.
For more information see our policy on the use of generative AI in application and assessment.
Deadline
We must receive your application by 6 November 2024 at 4:00pm UK time.
You will not be able to apply after this time.
Make sure you are aware of and follow any internal institutional deadlines.
Following the submission of your application to the funding opportunity, your application cannot be changed, and applications will not be returned for amendment. If your application does not follow the guidance, it may be rejected.
Personal data
Processing personal data
The Medical Research Council (MRC), as part of UKRI, will need to collect some personal information to manage your Funding Service account and the registration of your funding applications.
We will handle personal data in line with UK data protection legislation and manage it securely. For more information, including how to exercise your rights, read our privacy notice.
Sensitive information
If you or a core team member need to tell us something you wish to remain confidential, email dpfsanddcs@mrc.ukri.org
Include in the subject line: [the funding opportunity title; sensitive information; your Funding Service application number].
Typical examples of confidential information include:
- individual is unavailable until a certain date (for example due to parental leave)
- declaration of interest
- additional information about eligibility to apply that would not be appropriately shared in the ‘Applicant and team capability’ section
- conflict of interest for UKRI to consider in reviewer or panel participant selection
- the application is an invited resubmission
For information about how UKRI handles personal data, read UKRI’s privacy notice.
Publication of outcomes
MRC, as part of UKRI, will publish the outcomes of this funding opportunity at board and panel outcomes.
If your application is successful, we will publish some personal information on the UKRI Gateway to Research.
Summary
Word limit: 550
In plain English, provide a summary we can use to identify the most suitable experts to assess your application.
We usually make this summary publicly available on external-facing websites, therefore do not include any confidential or sensitive information. Make it suitable for a variety of readers, for example:
- opinion-formers
- policymakers
- the public
- the wider research community
Guidance for writing a summary
Clearly describe your proposed work in terms of:
• context
• the challenge the project addresses
• aims and objectives
• potential applications and benefits
If your application relates to the Artificial intelligence, engineering biology and quantum technologies highlight notice, you should also refer to this and the critical technology in your summary.
Core team
List the key members of your team and assign them roles from the following:
- project lead (PL)
- project co-lead (UK) (PcL)
- project co-lead (international) (PcL (I))
- specialist
- grant manager
- professional enabling staff
- research and innovation associate
- technician
- visiting researcher
- researcher co-lead (RcL)
Only list one individual as project lead. If you include more than one project lead your application will fail at the checking stage.
Public contributors should be added to your application under the ‘specialist’ role within the core team (if applicable).
Find out more about UKRI’s core team roles in funding applications.
Application questions
Related applications
Word limit: 2,200
Provide a response to feedback from your stage one Developmental Pathway Funding Scheme (DPFS) application or previous stage two DPFS application.
What the assessors are looking for in your response
Ensure you describe:
- how this application differs from the previous application
- how previous feedback has been considered and addressed
Please identify, if applicable, if your application is a resubmission to DPFS, including any invitations from us permitting your resubmission and previous reference number.
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
Opportunity and market
Word limit: 1,500
What is the opportunity or challenge, you are seeking to address?
What the assessors are looking for in your response
Ensure you describe:
- the health or clinical need you are seeking to address
- how your work could lead to the development of a new or improved prototype, product, service or technology
- how meeting this need could significantly reduce disease burden or alleviate an important clinical or translational bottleneck
- the competing solutions and their status, including whether similar or complementary research is being taken elsewhere
- the key competitive advantages of your proposed solution
- the potential market for your proposed solution, quantify this in terms of the target product profile, patient numbers and financial parameters
Building on your stage one application, you should also describe in detail:
- the timeliness of your approach
- the end users of your proposed solution, such as clinicians, primary care staff, technical specialists
- any engagement with end users, patients, carers or the wider public in the development of the project
- any further needs that could be addressed by your proposed solution or components of it, such as use as a platform technology
Scientific background and current stage of development
Word limit: 2,500
What is the background to this application and evidence to support the proposed solution?
What the assessors are looking for in your response
Ensure that you provide:
- a detailed description of the current stage of development
- an overview of the rationale and scientific background of your application
- updated information about your previous or current funding (if applicable) that has enabled and informed the proposed work, include any previous UKRI grant references. If you will have any funding concurrent to this project, explain any overlap and how that funding will support the proposed work
- in the case of applications involving institutes, units or centres with existing core funding, including those funded by UKRI and National Institute for Health and Care Research (NIHR) such as Biomedical Research Centres (BRCs), describe how the proposed work and resources requested builds on, but is distinct from, core funded programmes of research
In this section, you must also provide supporting data (including a small selection of figures, tables and images where relevant) to demonstrate the current development stage of your project and proof-of-concept to support your application. Further details are provided in the Funding Service.
Small molecule supplementary information
Word limit: 1,500
If you are requesting funding for a hit to lead, lead optimisation or candidate selection project, please provide structures.
What the assessors are looking for in your response
If your application is not about hit-to-lead and lead optimisation, enter ‘N/A’ in the text box, mark this section as complete and move to the next question.
Download and complete the DPFS small molecule supplementary information form (DOCX, 48KB), then paste the table into the text box.
Using the following headings, ensure that you provide target product profile (TPP) or key target compound parameters of the proposed investigational new drug (IND):
- target name
- mechanism of action, such as agonist, antagonist
- route of administration, such as oral, IV, topical
- duration of treatment, such as acute or chronic
- dosage regimen, such as twice daily
Structure and data
You should:
- provide structures for the most promising chemical series being actively developed. Failure to include chemical structures may negatively impact the ability to assess the suitability or strengths of your proposed chemistry plan
- use the table as a template, summarise the available data in the same column for each series
Data are requested for any available assays for the lead molecule shown and the range seen within the chemical series, including (but not limited to):
- biological assays
- physicochemical properties
- liabilities and development risks for up to two chemotypes or chemical series
Project tractability
You should:
- summarise the main structure activity or property relationships for each chemical series
- highlight the key challenges to optimisation of the series towards the TPP and outline how these will be addressed
- describe the biological assays and models to be used in the project including their duration and throughput where relevant
- explain how risk associated with the translation between in vivo assays, in vivo models, and activity in humans will be minimised
Development plan and route to patient benefit
Word limit: 1,000
What is the proposed approach for further development, and how will the project progress the innovation or technology towards achieving market or health or patient benefits?
What the assessors are looking for in your response
Using the following headings, ensure you describe in detail:
Current development plan
You should describe:
- how the proposed work will enable its development
- the project’s primary objectives
- the project endpoint that would indicate that there is a reasonable chance of attracting onward investment
- the expertise or any consultancy required to deliver the proposed work
- how the proposed work will inform or deploy the product or technology using the most appropriate route to market or patient benefit
Exit strategy
You should describe:
- what further support you may need, following this funding, to deliver your product or technology, such as access to further funding, networks, partnerships, private investment and skills
- the criteria that would need to be met to access the further support
- if you are ultimately seeking to develop a commercial product, the potential market value and how this will be realised such as business development plans
- any engagement taken place or planned with potential downstream funders, partners or regulators, outlining who they are and the status of discussions
- the plans and strategy for further development, outlining the planned route to achieving patient benefits following the end of the DPFS project
Approach
Word limit: 3,500
How are you going to deliver your proposed work?
What the assessors are looking for in your response
Provide a project plan with robust experimental design and risk management to support your development.
Project plan
Provide a detailed project workplan which should include:
- project specific deliverables
- a minimum of two key progression milestones (one being the project end)
- project’s starting point and approaches proposed to deliver the planned objectives
- the overall timeframe of the project
- the resourcing necessary to deliver the proposed work
- any regulatory approvals required. If you have consulted with the relevant regulatory body or experts, please summarise the outcome of the discussions
You should also include the project management requirements, including the commitment and involvement from your:
- research office
- translational research office, your technology transfer office or both (include key contact and their positions)
To support your project plan, you must also embed a Gantt chart in the text box that includes:
- project tasks (these being short, achievable and measurable activities) with, where relevant, the party responsible for delivering the task and dependency between tasks
- milestones which are major specifically-timed ‘Go or No-go’ decision points
You should check the readability of your embedded ‘Gantt chart’ using the ‘read view’ on the Funding Service. Sizes of images can be adjusted when editing within the text box.
Methodology and experimental design
As part of your methodology and experimental design, ensure that you describe:
- the use of animals or patients, including justification for why particular animal models or clinical populations have been chosen, following the MRC embedding diversity in research design policy
- if applicable, show how you will use both sexes in research involving animals and tissues and cells. If you are not proposing to do this, a strong justification is required
- any consultation with a statistician or methodology hub to the development of the proposal
- the access you will have to statistical support during the project
- for clinical studies, the recruitment and retention strategy
- explain and justify the inclusion of public partnerships (if applicable) and the added value these offer
Please refer to the MRC guidance for applicants, for further information.
Use the ‘Research involving the use of animals’ section to provide information on the rationale for using animals, choice of species, welfare and procedure severity.
The National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) have developed a free online tool to guide researchers through the design of their experiments. It helps to ensure that researchers use the minimum number of animals consistent with their scientific objectives, methods to reduce subjective bias, and appropriate statistical analysis.
Risk management
Describe the key risks to the project and your risk management plan, including:
- how likely the risks are to occur
- what their impact would be on the success and deliverability of the project
- how these risks will be managed, by whom and related escalation or mitigations procedures
You may use a risk table if preferred.
Environment, infrastructure and equipment
Describe how your, and if applicable your team’s, research environment (in terms of the place and relevance to the project) will contribute to the success of the work.
Demonstrate access to the appropriate services, facilities, infrastructure, or equipment to deliver the proposed work, including:
- specialist equipment or infrastructure required to deliver the project objectives
- proposed use of existing joint research facilities
- proposed use of existing clinical infrastructure, for example the Experimental Cancer Medicine Centre Network, NIHR biomedical research centres, NIHR clinical research facilities, patient cohorts
- if not already in place, explain how you will ensure this infrastructure is accessible by the project start date
We suggest you structure your response using the following headings, with approximate word counts for each:
- project plan: 1,500 words
- methodology and experimental design: 750 words
- risk management: 450 words
- environment, infrastructure and equipment: 450 words
- references: 350 words
Do not use the project plan to include information which should be detailed in the other sections of your application.
References may be included within this section.
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
Reproducibility and statistical design
Word limit: 500
How will you ensure your proposed work is reliable, robust and reproducible?
What assessors are looking for in your response
Information about reproducibility and how you will ensure reliability and robustness of your proposed work, such as further details of statistical analyses, methodology and experimental design, not provided in your approach.
We expect you to seek professional statistical or other relevant advice in preparing your response, which should include, as appropriate:
- sample and effect sizes
- planned statistical analyses
- models chosen (for example animal model, cell line)
- potential sources of bias and how these will be mitigated during analysis
- how your approach to addressing diversity is reflected in the experimental design and analyses
Refer to the MRC guidance for applicants, for further information, examples and online tools.
If your proposed work involves animals, and you provide information on animal sample sizes and statistical analyses here, you should not duplicate it in the Research involving the use of animals section. Use the ‘Research involving the use of animals’ section to provide information on the rationale for using animals, choice of species, welfare and procedure severity.
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
The length of your response will vary depending on the type of project, you may not need to use 500 words.
Milestones
Word limit: 1,500
Provide details of your project milestones.
What the assessors are looking for in your response
Provide at least two key progression milestones for your project, that:
- delineate the proposed work into costed project phases with clear ‘go or no-go’ decision points
- provides the success criteria that will be used for each milestone, with target and acceptable thresholds
Download and complete the following milestone template (DOCX, 49KB) and copy and paste into the text box. You may add as many milestones as needed for your project.
Milestones must be SMART, that is specific, measurable, achievable, relevant, and time-framed:
- detail robust ‘go or no-go’ criteria (failure to meet these will result in early termination of the project)
- for all projects, it is advisable to structure the project so that the critical questions are addressed as early as possible in the plan
Success criteria should be based on project outputs that, at the given point, need to be achieved in order to justify further continuation of the studies. Success criteria should align to project aims and objectives; success criteria for the final milestone should reflect what success for the funded aspect of the project would equate to.
For each success criterion, please specify a quantified target value that you will seek to attain and a quantified acceptable value, which, if achieved, would support project progression.
For clinical studies, this should include a summary of:
- study design
- study participants
- study endpoints
- dose (when applicable)
- analysis plans
Do not include project management meetings or other process-related tasks as milestone success criteria.
Your estimate of the milestone criteria being met should assume that the preceding milestone was achieved.
For the final milestone, the criteria should reflect outcomes representing successful completion of the project.
Applicant and team capability to deliver
Word limit: 1,650
Why are you the right individual or team to successfully deliver the proposed work?
What the assessors are looking for in your response
Evidence of how you, and if relevant your team, have:
- the relevant experience (appropriate to career stage) to deliver the proposed work
- the right balance of skills and expertise to cover the proposed work
- the appropriate leadership and management skills to deliver the work and your approach to develop others
- contributed to developing a positive research environment and wider community
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
The word limit for this section is 1,650 words: 1,150 words to be used for R4RI modules (including references) and, if necessary, a further 500 words for Additions.
Use the Résumé for Research and Innovation (R4RI) format to showcase the range of relevant skills you and, if relevant, your team (project and project co-leads, researchers, technicians, specialists, partners and so on) have and how this will help deliver the proposed work. You can include individuals’ specific achievements but only choose past contributions that best evidence their ability to deliver this work.
Complete this section using the R4RI module headings listed. Use each heading once and include a response for the whole team, see the UKRI guidance on R4RI. You should consider how to balance your answer, and emphasise where appropriate the key skills each team member brings:
- contributions to the generation of new ideas, tools, methodologies, or knowledge
- the development of others and maintenance of effective working relationships
- contributions to the wider research and innovation community
- contributions to broader research or innovation users and audiences and towards wider societal benefit, including public partnerships
Additions
Provide any further details relevant to your application. This section is optional and can be up to 500 words. You should not use it to describe additional skills, experiences, or outputs, but you can use it to describe any factors that provide context for the rest of your R4RI (for example, details of career breaks if you wish to disclose them).
Complete this as a narrative. Do not format it like a CV.
References may be included within this section.
UKRI has introduced new role types for funding opportunities being run on the new Funding Service.
For full details, see Eligibility as an individual.
Intellectual property (IP) management and dissemination of project outcomes
Word limit: 1,500
Attachment: International Search Report (five pages)
What IP will be generated and how would it be managed during the project?
What the assessors are looking for in your response
If the project is not generating any new IP, please enter ‘N/A’ in the section and move on.
IP is a collective term for all intangible assets such as data, clinical trial results, software, know-how, materials, inventions, methods, designs and the associated intellectual property rights (including patents, copyright and trademarks).
The generation of protectable intellectual property is not an essential requirement for DPFS. Projects that will not generate patentable materials but that will nevertheless have the potential to provide health benefits are accepted on an equal basis. However, ownership and management of IP must be consistent with our funding requirements.
Projects with no plausible route to exploitation and ultimate health benefit or impact are extremely unlikely to be supportable.
Using the following headings where applicable:
IP generation and management
You should:
- describe any new intellectual property or knowledge that the project is expected to generate
- explain how any intellectual assets generated will be managed throughout the project to enable further development and ensure future success
- detail the organisations or individuals who will own any arising IP and any live, pending or envisioned agreements governing ownership or exploitation of that IP
Prior art
You should:
- list all existing technologies and IP that will be developed or utilised as part of your DPFS project. Please include patent numbers, patent claim coverage, ownership and status where relevant
- provide a summary of the most relevant prior art, with details on the database searched, dates of the searches and the search terms. You may upload a summary of international search report (up to five A4 pages) to support your application
- describe the potential impact of prior art on the strategy for protection of IP, including any disclosure of background IP by the applicants or a third party
Freedom to operate
You should:
- explain if the applicants have freedom to operate for this project, for future development work, or for clinical use. If access is required, what IP does the project need access to for future development
- if access to background IP is required, detail the organisations or individuals that hold the relevant background IP rights. If this background IP is held by a third party (or a non-academic applicant), has access been agreed? If not, why do you believe you will be able to access the required IP on reasonable terms
Conflict of interest and management
You should:
- explain if any of the academic applicants have an interest in the commercial owners of background technologies or IP, such as shareholding options or consultancy fee, and what is the nature of their interest and how are conflicts of interest being managed
Project partners
Add details about any project partners’ contributions. If there are no project partners, you can indicate this on the Funding Service.
A project partner is a collaborating third party organisation who will have an integral role in the proposed research. This may include direct (cash) or indirect (in-kind) contributions such as expertise, staff time or use of facilities. Project partners may be in industry, academia, third sector or government organisations in the UK or overseas, including partners based in the EU.
Important note: If your application includes industry project partners, you will also need to complete the Industry Collaboration Framework (ICF) section. Find out more about ICF.
You must ensure that any third-party individual or organisation you include within the Funding Service as a project partner, also provides you with a supporting email or letter of support (see next section ‘Project partners: letters or emails of support’).
The individual named as the project partner contact, cannot be included in your application as a member of the core team, in any core team role.
The project partner organisation cannot be an applicant organisation, where any member of the core team is based. For example, you cannot include a different department based within the applicant organisation as a project partner.
If an individual or organisation outside the core team is responsible for recruitment of people as research participants or providing human tissue for this project, list them as a project partner.
Add the following project partner details:
- the organisation name (searchable via a drop-down list or enter the organisation’s details manually, as applicable)
- the project partner contact name and email address
- the type of contribution (direct or in-direct) and its monetary value
If there are specific circumstances where project partners do require funding for minor costs such as travel and subsistence, these project partner costs should be claimed and justified within the resources and costs section of your application.
If a detail is entered incorrectly and you have saved the entry, remove the specific project partner record and re-add it with the correct information.
For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made.
Project partners: letters (or emails) of support
Word limit: 10
Upload a single PDF containing the letters or emails of support from each partner you named in the ‘Project partners’ section. These should be uploaded in English or Welsh only.
What the assessors are looking for in your response
Enter the words ‘attachment supplied’ in the text box, or if you do not have any project partners enter ‘N/A’.
What supporting statements we are looking for
Important note: We are only looking for you to provide project partner letters or emails of support from the following:
- a third-party individual
- a third-party organisation
Third party means the individual and organisation must not be involved in the application core team. You must ensure that any project partners providing a supporting document, are also added to the ‘Project partners’ section within the Funding Service.
What supporting statements we are not looking for
We are not looking for you to provide any letters or emails of support from individuals or organisations included in your application core team (this includes other departments within the same organisation). Any individual or organisation included in your application with a core team role cannot also be a project partner.
Do not include any other statements or any other type of information we have not requested, including letter or emails of support from colleagues simply expressing supportive opinions. We only expect letters or emails of support from your third-party project partners to be uploaded to this section.
If you include any information not requested by MRC, your application will be rejected.
Supporting letter and email guidance for third party project partners
Each project partner letter or email you provide should:
- confirm the partner’s commitment to the project
- clearly explain the value, relevance, and possible benefits of the work to them
- describe any additional value that they bring to the project
- include the name of the project partner organisation and contact information (this should match the partner contact and organisation name details you must add to the ‘Project partners’ section)
- have a page limit of two sides of A4 per partner
Project partners’ letters and emails of support are not required to be on headed paper or include handwritten signatures (electronic signatures are acceptable from the nominated partner contact).
Industry or company project partner letter and email of support guidance
Industry or company project partners are required to complete the industry or company letter of support template by exploring the document download section of MRC Industry Collaboration Framework (ICF) this will ensure the letter or email they provide you, contains all the relevant information we need.
Project partner responsibility for the recruitment of people
If the project partner is responsible for the recruitment of people as research participants or providing human tissue their letter or email of support should include:
- agreement that the project partner will recruit the participants or provide tissue
- confirmation that what is being supplied is suitable for the proposed work
- confirmation that the quantity of tissue being supplied is suitable, but not excessive for achieving meaningful results (if applicable)
Multiple project partners
If you have multiple project partners, you should:
- ensure each separate partner letter or email of support, does not exceed two pages of A4
- consolidate all the supporting documents provided by each project partner into a single PDF file before uploading
- ensure the PDF does not exceed the maximum file size of 8MB
The Funding Service will provide document upload details when you apply.
If you do not have any project partners, you will be able to indicate this in the Funding Service.
Ensure you have prior agreement from project partners so that, if you are offered funding, they will support your project as indicated in the ‘Project partners’ section.
For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made.
Industry Collaboration Framework (ICF)
Word limit: 1,500
Does your application include collaboration with industry or company project partners?
What the assessors are looking for in your response
The assessors are looking for you to confirm if your proposed work involves collaboration with an industry or company project partner. If it does, you will need to follow the MRC industry collaboration framework (ICF).
By ‘industry or company’ we mean an enterprise that puts or has intention to put goods or services on a market.
For guidance to assist your decision if your proposed work requires you to follow ICF, you should explore the ICF decision tree and find out more about ICF which includes:
- collaboration agreements
- definitions of basic or applied research
- internationally based companies
- subsidy control
- intellectual property (IP) arrangements
- fully flexible and gated contributions
- the ICF assessment criteria
Enter ‘Yes’ in the text box if you have industry or company project partners and you are likely to follow ICF. You should also confirm your answers to the ICF questions one to nine in the text box for each ICF project partner.
Contact dpfsanddcs@mrc.ukri.org if you are unsure if your application should follow ICF.
In addition to the project partner information completed in the previous section, the assessors are looking for information relating to the nature, goals and conditions of the collaboration and any restrictions or rights to the project results that could be claimed by the industry or company project partner.
Confirm your answers to the ICF questions in the text box, repeat this process for each ICF project partner:
- Name the industry or company project partner considered under ICF.
- Indicate whether your application is basic research or applied research.
- Explain why, in the absence of the requested UKRI funding, the collaboration and the planned research could not be undertaken.
- State whether your application is under the category of fully flexible contribution or gated contribution (based on the IP sharing arrangements with the industry or company).
- Outline the pre-existing IP (‘background IP’) that each partner, including the academic partner, will bring to the collaborative research project and the terms under which partners may access these assets.
- Outline the IP that is expected to be developed during the collaborative research project (‘foreground IP’) and briefly outline how it will be managed, including:
- who will own this IP
- what rights industry or company partners will have to use academically-generated foreground IP during and after the research project, for internal research and development or for commercial purposes
- any rights of the academic partner to commercialise the foreground IP, including foreground IP generated by industry or company partners
- Outline any restrictions to dissemination of the project results, including the rights of the industry or company partner to:
- review, approve or delay publications (including the time period associated with such rights)
- request or require the removal of any information
- Declare any conflicts of interest held by the applicants in relation to the industry or company project partners and describe how they will be managed.
- Justify collaborating with an overseas industry or company under ICF (if applicable).
Failure to provide the information requested for industry or company partners under ICF could result in your application being rejected.
You are recommended to discuss the goals and conditions of any collaboration with an industry or company with your technology transfer or contracts office before applying.
For audit purposes, UKRI requires formal collaboration agreements to be put in place if an award is made. You must provide us with a copy of the collaboration agreement, signed by all partners, before an ICF award starts.
If this does not apply to your proposed work, you will be able to indicate this in the Funding Service.
Trusted Research and Innovation
Word limit: 100
Does the proposed work involve international collaboration in a sensitive research or technology area?
What the assessors are looking for in your response
Demonstrate how your proposed international collaboration relates to Trusted Research and Innovation, including:
- list the countries your international project co-leads, project partners and visiting researchers, or other collaborators are based in
- if international collaboration is involved, explain whether this project is relevant to one or more of the 17 areas of the UK National Security and Investment (NSI) Act
- if one or more of the 17 areas of the UK National Security and Investment (NSI) Act are involved, list the areas
If your proposed work does not involve international collaboration, you will be able to indicate this in the Funding Service.
We may contact you following submission of your application to provide additional information about how your proposed project will comply with our approach and expectation towards TR&I, identifying potential risks and the relevant controls you will put in place to help manage these risks.
Data management and sharing
Word limit: 1,500
How will you manage and share data collected or acquired through the proposed research?
What the assessors are looking for in your response
Provide a data management plan which should clearly detail how you will comply with MRC’s published data management and sharing policies, which includes detailed guidance notes.
Provide your response in the text box following the headings in the MRC data management plan template. You are not required to upload the document to your application.
The length of your plan will vary depending on the type of study being undertaken:
- population cohorts’ longitudinal studies, genetic, omics and imaging data, biobanks, and other collections that are potentially a rich resource for the wider research community: maximum of 1,500 words
- all other research, less complex: the plan may be as short as 500 words
Ethics and responsible research and innovation (RRI)
Word limit: 500
What are the ethical or RRI implications and issues relating to the proposed work? If you do not think that the proposed work raises any ethical or RRI issues, explain why.
What the assessors are looking for in your response
Demonstrate that you have identified and evaluated:
- the relevant ethical or responsible research and innovation considerations
- how you will manage these considerations
Consider the MRC guidance on ethics and approvals.
You may demonstrate elements of your responses in visual form if relevant. Further details are provided in the Funding Service.
Genetic and biological risk
Word limit: 700
Does your proposed research involve any genetic or biological risk?
What the assessors are looking for in your response
In respect of animals, plants or microbes, are you proposing to:
- use genetic modification as an experimental tool, like studying gene function in a genetically modified organism
- release genetically modified organisms
- ultimately develop commercial and industrial genetically modified outcomes
If yes, provide the name of any required approving body and state if approval is already in place. If it is not, provide an indicative timeframe for obtaining the required approval.
Identify the organism or organisms as a plant, animal or microbe and specify the species and which of the three categories the research relates to.
Identify the genetic and biological risks resulting from the proposed research, their implications, and any mitigation you plan on taking. Assessors will want to know you have considered the risks and their implications to justify that any identified risks do not outweigh any benefits of the proposed research.
If this does not apply to your proposed work, you will be able to indicate this in the Funding Service.
Research involving the use of animals
Word limit: 10
Does your proposed research involve the use of vertebrate animals or other organisms covered by the Animals Scientific Procedures Act?
What the assessors are looking for in your response
If you are proposing research that requires using animals, download and complete the Animals Scientific Procedures Act template (DOCX, 74KB), which contains all the questions relating to research using vertebrate animals or other Animals (Scientific Procedures) Act 1986 regulated organisms.
Save it as a PDF. The Funding Service will provide document upload details when you apply. If this does not apply to your proposed work, you will be able to indicate this in the Funding Service.
Conducting research with animals overseas
Word limit: 700
Will any of the proposed animal research be conducted overseas?
What the assessors are looking for in your response
If you are proposing to conduct overseas research, it must be conducted in accordance with welfare standards consistent with those in the UK, as in Responsibility in the use of animals in bioscience research, page 14. Ensure all named applicants in the UK and overseas are aware of this requirement.
If your application proposes animal research to be conducted overseas, you must provide a statement in the text box. Depending on the species involved, you may also need to upload a completed template for each species listed.
Statement
Provide a statement to confirm that:
- all named applicants are aware of the requirements and have agreed to abide by them
- this overseas research will be conducted in accordance with welfare standards consistent with the principles of UK legislation
- the expectation set out in Responsibility in the use of animals in bioscience research will be applied and maintained
- appropriate national and institutional approvals are in place
Templates
Overseas studies proposing to use non-human primates, cats, dogs, equines or pigs will be assessed during NC3Rs review of research applications. Provide the required information by completing the template from the question ‘Research involving the use of animals’.
For studies involving other species, select, download, and complete the relevant Word checklist or checklists from this list:
Explore NC3Rs checklist for the use of animals overseas
Save your completed template as a PDF and upload to this section, following the guidance provided. If you use more than one checklist template, consolidate each checklist as a single PDF.
The Funding Service will provide document upload details when you apply.
If conducting research with animals overseas does not apply to your proposed work, you will be able to indicate this in the Funding Service.
Research involving human participation
Word limit: 700
Will the project involve the use of human subjects or their personal information?
What the assessors are looking for in your response
If you are proposing research that requires the involvement of human subjects, provide the name of any required approving body and whether approval is already in place.
Justify the number and the diversity of the participants involved, as well as any procedures.
Provide details of any areas of substantial or moderate severity of impact.
If this does not apply to your proposed work, you will be able to indicate this in the Funding Service.
Research involving human tissues or biological samples
Word limit: 700
Does your proposed research involve the use of human tissues, or biological samples?
What the assessors are looking for in your response
If you are proposing work that involves human tissues or biological samples, provide the name of any required approving body and whether approval is already in place.
Justify the use of human tissue or biological samples specifying the nature and quantity of the material to be used and its source.
If this does not apply to your proposed work, you will be able to indicate this in the Funding Service.
Resources and cost justification
Word limit: 1,200
What will you need to deliver your proposed work and how much will it cost?
What the assessors are looking for in your response
Justify the application’s more costly resources, in particular:
- project staff
- significant travel for field work or collaboration (but not regular travel between collaborating organisations or to conferences)
- any equipment that will cost more than £10,000
- any consumables beyond typical requirements, or that are required in exceptional quantities
- all facilities and infrastructure costs
- costs requested as exceptions
- costs for public and patient involvement and engagement. Costs for public partnerships including payments to public partners can be included under the exceptions heading
- costs for preserving, long-term storage, or sharing of data
- cost for international co-leads, demonstrating this is within the 30% costs cap for co-leads from high income countries, India and China. There is no cap on costs requested for international applicants from DAC list countries
- NHS research costs, when they are associated with NHS studies
- animal costs, such as numbers that need to be bred or maintained and to maintain high welfare standards
- outsourcing work
Outsourcing work
We recognise that sometimes it may be appropriate to outsource elements of your work. If that is the case, provide the following:
- the scope of the outsourced activity: what is being undertaken and what will be delivered
- the relevance of the outsourced activity to the application
- why the outsourced activity cannot be undertaken in-house
- why this provider is the most appropriate
- the cost(s) of the outsourced activity and the tendering process to be followed
- details of any conflicts of interest (potential or actual) between parties and how they will be managed
Detailed costs or a line-by-line breakdown of all project resources are not required. Overall, you should demonstrate how the resources you anticipate needing for your proposed work:
- are comprehensive, appropriate, and justified
- represent the optimal use of resources to achieve the intended outcomes
- maximise potential outcomes and impacts
Clinical research using NHS resources
Word limit: 250
Are you applying to do clinical research in the UK?
What the assessors are looking for in your response
Researchers applying to do clinical research in the NHS, public health or social care usually need to complete a Schedule of Events Cost Attribution Tool (SoECAT).
We request the SoECAT because we want to know that you have taken the appropriate steps to request National institute for Health and Care Research (NIHR) support and for the full costs of your research to be attributed, calculated and paid.
We want to see the expected total resources required for your project to consider if these are appropriate.
Enter ‘Yes’ and complete and upload a SoECAT if you are applying for clinical research and:
- you will carry out your research in the UK
- your research will use NHS resources
- the research requires approval by Health Research Authority (England) or its equivalents in Northern Ireland, Scotland or Wales
- you will need support from the NIHR Research Delivery Network, this may include studies in a social care or public health setting
It is important to complete a SoECAT to be eligible for NIHR support. You must complete a SoECAT even if you do not think your clinical research will involve excess treatment costs (ETCs).
See MRC guidance on who needs to complete a SoECAT.
How to complete a SoECAT
SoECAT guidance can be found on the NIHR website.
These are the steps you need to take:
- Contact an attributing the costs of health and social care research and development (AcoRD) specialist as early as possible in the application process.
- Complete an online SoECAT. Excel versions of the form have been discontinued. If you do not have an account for NIHR’s Central Portfolio Management System (CPMS) you will need create and activate one. See the user guide for instructions
- Request authorisation of your SoECAT.
- Once authorised, extract the ‘study information’ and the ‘summary’ page from the ‘Funder Export’, combine them as a single PDF and upload it to your application.
Applications that require a SoECAT but have not attached the SoECAT funder export study information and summary may be rejected.
Ensure the AcoRD specialists name and date are include within the uploaded summary page. The SoECAT is invalid without this information.
Contact dpfsanddcs@mrc.ukri.org if you have questions about the UKRI aspects of this process or have concerns that your SoECAT may not be authorised in time for the application closing date.
If this does not apply to your proposed work, you will be able to indicate this in the Funding Service.
